English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  51112177    在线人数 :  993
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"tsai m f"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 136-145 / 194 (共20页)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2020-03-07T06:56:10Z Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer Liu Y.-N.;Tsai M.-F.;Wu S.-G.;Chang T.-H.;Tsai T.-H.;Gow C.-H.;Yih-Leong Chang;Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Wu S.-G.; Chang T.-H.; Tsai T.-H.; Gow C.-H.; YIH-LEONG CHANG; Shih J.-Y.
臺大學術典藏 2020-03-06T05:26:40Z Transcription repressor Slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma Yang P.-C.; Lee Y.-C.; Su J.-L.; Yang S.-C.; Hong T.-M.; Chen J.J.W.; Lee M.-L.; Liou G.-Y.; Lin S.-B.; Shih J.-Y.; Tsai M.-F.; Chang T.-H.; YIH-LEONG CHANG; Yuan A.; Yu C.-J.
臺大學術典藏 2020-03-06T05:26:38Z Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer Shih J.-Y.; Gow C.-H.; Yu C.-J.; Yang C.-H.; YIH-LEONG CHANG; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; Yang P.-C.
臺大學術典藏 2020-03-06T05:26:30Z Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern Wu S.-G.; YIH-LEONG CHANG; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-03-06T05:26:29Z Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer Gow C.-H.; YIH-LEONG CHANG; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; Yu C.-J.; Yang C.-H.; Lee Y.-C.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2020-03-06T05:26:24Z Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction Wu S.-G.; YIH-LEONG CHANG; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Tsai M.-F.; Lee Y.-C.; Yu C.-J.; Shih J.-Y.
臺大學術典藏 2020-03-06T05:26:22Z EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR Tsai M.-F.; Yu C.-J.; Yang C.-H.; Yang P.-C.; Wu S.-G.; Kuo Y.-W.; YIH-LEONG CHANG; Shih J.-Y.; Chen Y.-H.
臺大學術典藏 2020-03-06T05:26:22Z Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma Tsai T.-H.; Wu S.-G.; YIH-LEONG CHANG; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2020-03-06T05:26:17Z Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; YIH-LEONG CHANG; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.
臺大學術典藏 2020-03-06T05:26:09Z The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients Wu S-G.; Liu Y.-N.; Tsai M.-F.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.

显示项目 136-145 / 194 (共20页)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
每页显示[10|25|50]项目